Literature DB >> 12986408

[Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)].

J DELAY, P DENIKER, J M HARL.   

Abstract

Entities:  

Keywords:  MUSCLE RELAXANTS/therapeutic use; PHENOTHIAZINE/derivatives; PSYCHOSES/therapy

Mesh:

Substances:

Year:  1952        PMID: 12986408

Source DB:  PubMed          Journal:  Ann Med Psychol (Paris)        ISSN: 0003-4487            Impact factor:   0.380


× No keyword cloud information.
  53 in total

1.  A DOUBLE-BLIND COMPARISON OF THIORIDAZINE AND CHLORPROMAZINE.

Authors:  J R STABENAU; D R GRINOLS
Journal:  Psychiatr Q       Date:  1964-01

2.  [Phenothiazine and phagocytosis of leukocytes].

Authors:  G LUDANY; J VAJDA; A DOKLEN
Journal:  Acta Neuroveg (Wien)       Date:  1959

3.  Effects of largactil in mental syndromes.

Authors:  H AZIMA; W OGLE
Journal:  Can Med Assoc J       Date:  1954-08       Impact factor: 8.262

Review 4.  From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?

Authors:  A Richard Green; Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 5.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone.

Authors:  Ofer Agid; Phillip Seeman; Shitij Kapur
Journal:  J Psychiatry Neurosci       Date:  2006-03       Impact factor: 6.186

Review 6.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

Review 7.  The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Authors:  Gerhard Gründer; Hanns Hippius; Arvid Carlsson
Journal:  Nat Rev Drug Discov       Date:  2009-02-13       Impact factor: 84.694

Review 8.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 9.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

10.  Fifty years chlorpromazine: a historical perspective.

Authors:  Thomas A Ban
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.